In 2006, the FDA approved a single-rod, etonogestrel-releasing subdermal implant (ENG implant) or Implanon®. In November 2011, Nexplanon® was released. Nexplanon has a redesigned inserter ...

Discontinuation rates were 17% (30 out of 175) and 43.4% (76 out of 175), respectively ... of this manuscript. The etonogestrel-releasing subdermal (ENG) implant is the most effective reversible ...